Havana.- The Center for Research and Development of Medicines (CIDEM by its Spanish acronym), belonging to BioCubaFarma business group, has 48 projects in research of products for human use, announced an expert of that institution.
Dr. Orlando Perdomo, CICEM Director of Research and Development, told ACN that the portfolio is divided into innovative lines that are in turn in new chemical entities, drugs and molecules.
He also said that they have therapeutic forms, known as super generic by being an additional benefit to the conventional medicine, and added that innovative medicines include generic ones, natural products and those related to health.
In the last months, this institution developed the first effervescent tablets of chlorine destined to the disinfection of water, a technology used in Cuba for the first time with very high effectiveness for the potabilization of the precious liquid, emphasized the specialist.
Perdomo announced that an investment was planned to increase six times the production of the current plant and is projected to build a larger one in Mariel Special Development Zone.
Another line developed by CIDEM is Neolimpilen, intended for the cleaning of contact lenses, which is used as a moisturizer and antiseptic and has lubricating and stabilizing activity.